The poster can be downloaded free of charge from NOAH’s Pet Health Info website and a limited number are available from NOAH free of charge on a first-come, first-served basis.
Featuring pet photos from NOAH’s 'Happy healthy pets' project gallery, the planner contains independent seasonal expert tips and advice for pets: from exercise, diet and healthcare to keeping them safe and comfortable in different weather conditions.
Over the coming months, the campaign will continue to roll out tips and expert advice from NOAH and partners, tailored web content, as well as press and social media activity.
The poster is part of ’I Heart My Pet’ campaign, now in its third year, which includes the Happy, Healthy Pets Project – an interactive online gallery, where pet owners have already uploaded more than 2000 images of happy, healthy pets.
NOAH Chief Executive, Dawn Howard said: "We are thrilled that these three great animal welfare charities have joined forces with NOAH to help extend the reach of our collective networks on this project, with the ultimate objective of improving the health of the UK’s pets.
"PDSA’s sterling work through its PAW Report, highlighting areas where we need to focus to improve pet welfare made them an obvious choice and we are delighted to be working with them on this. Cats Protection helps thousands of cats every year and provides invaluable information on cat care. We hope that by working together we’ll be able to assist them in helping many more.
RWAF’s work on educating owners about the responsibility involved in taking on rabbits as pets, through campaigns such as Rabbit Awareness Week, is of vital importance and we look forward to working closely with them to spread the word even further."
At 9.00am on Thursday and 1.45pm on Friday, Dr Sam Taylor, Feline Specialist and academy lead at the International Society of Feline Medicine (ISFM), will present ‘feline pawsative’, a talk about about cat inappetence and the remedy offered by Mirataz.
At 11.20am on Thursday and 9.00am on Friday, Matt Gurney, clinical director at Anderson Moores will be sharing the latest developments in sedation in dogs including Zenalpha.
At 12.30pm on Thursday and 12.35pm on Friday, Andrew Waller (pictured right), chief scientific officer at Intervacc AB, will be discussing how to rein in the impact of strangles using Dechra’s new protein-based vaccine, Strangvac.
The CPD sessions are first come, first served, and Dechra says it expects the presentations to be well-attended, so it could be worth getting there a little early, although probably no need to pitch a tent outside the night before.
The theme of Congress is 'Thriving in Practice' and there are five lecture streams:
To book your ticket visit https://spvs-congress.co.uk/congress-delegate-tickets/
Veterinary surgeon Andrew Reeder, Director of the Stonehenge Veterinary Hospital, in Durrington, near Salisbury, was the lucky winner of a Sony Pocket e-Reader in the Royal College of Veterinary Surgeons' prize draw at the London Vet Show in November.
The competition was mounted to launch an online quiz to test members' knowledge of the Guide to Professional Conduct. All those who completed the quiz on the RCVS stand at the event were entered into a prize draw: the RCVS would like to stress that it was a random draw, in spite of the serendipity of Andrew's surname!
"This is brilliant, I so rarely win anything!" said Andrew. "I'd recommend that all RCVS members should have a go at the quiz - it's quick, easy to complete and certainly makes you think."
Over 600 people have tackled the quiz so far. Those who fancy testing their knowledge of the Guide should visit www.rcvs.org.uk/guidequiz. The quiz is anonymous, but the College will be collating data to help focus future communications activities and see where extra guidance may be required. On completion of the quiz, it is possible to review answers and view the relevant section of the online Guide.
The introduction of the new Level 3 Diploma in Veterinary Nursing has seen an increase in numbers of both students and training practices, according to statistics released today by the RCVS.
Since January, the RCVS has approved over 30 more Training and Auxiliary Training Practices, bringing to a total of 1,559 the number of practices approved for veterinary nurse (VN) training. Scope for practices to train student VNs is increased through the emphasis on Auxiliary Training Practices (aTPs), an option for practices without the full facilities or caseload needed for student training. Students at aTPs complete their in-practice training at other aTPs or full Training Practices. Of the 31 new practices approved since January for student training, eight are aTPs.
The number of VN students enrolling with the RCVS has also increased, with almost double the number enrolling in January 2011, compared with January 2010. There were a total of 1,168 student enrolments in the 12 months from 1 February 2010, compared with 1,121 enrolments in the same period from 1 February 2009.
Libby Earle, Head of the RCVS Veterinary Nursing Department said: "The Level 3 Diploma has been in place for little more than six months, yet VN student numbers are already up. This bodes well for the supply of qualified, competent registered veterinary nurses demanded by veterinary practices, and for those keen to enter the veterinary nursing profession."
The qualification was introduced when the government abolished the National Vocational Qualification (NVQ) system last summer, forcing a change in the vocational qualifications for VNs. The resulting Level 3 Diploma is designed to better meet the needs of practices, colleges, and students themselves.
Dechra Veterinary Products has launched a webcast about feline hyperthyoidism, given by Tim Williams MA VetMB MRCVS from the Feline Research Group at the Royal Veterinary College.
During the ten minute webcast, entitled: 'The highs and lows of feline hyperthyroidism', Tim presents new evidence that overdosing hyperthyroid patients can lead to iatrogenic hypothyroidism, making them more likely to develop azotaemia and consequently have a shorter survival time. He also discusses the diagnosis and potential consequences of iatrogenic hypothyroidism based on recent research conducted at the Feline Research Group, and provides a summary of suggested treatment protocols. Tim said: "I hope the webcast helps veterinary staff optimise their treatment of hyperthyroid cats in practice and avoid a one size fits all approach".
Dechra says that research from 400 first opinion practices has shown that hyperthyroidism is the most commonly diagnosed feline endocrinopathy, with an annual incidence of 6% in cats over nine years old.
Tim's webcast is the latest in a series of online educational materials on endocrinology launched by Dechra as part of its Dechra Academy training suite.The webcast is available at http://www.dechra.co.uk/hyperthyroidism
Vétoquinol, makers of Zylkène, a complementary feed for cats and dogs, has launched www.zylkenepet.co.uk, a new website with advice for pet owners about how they can help their pet deal with unsettling situations.
The website offers a behavioural quiz to help identify whether a pet may need help coping with any changes taking place. In addition, the site offers tips and advice from behavioural experts together with guides to helping pets cope with situations such as moving home, the introduction of a new baby or new people, travelling and holidays, coping with kennel and cattery stays and fireworks.
Krystyna Joyce, Product Manager at Vétoquinol, said: 'Owners often give Zylkène when their pet needs a bit of extra support to deal with unusual situations and changes to their routine, but there are also lots of practical things you can do that will improve a pet's experience further during that time. We wanted to make sure that information was readily available through a succinct, user friendly website.'
The Fear Free movement was founded in 2016 by US veterinary surgeon Dr Marty Becker.
Marty said: “Just like with humans, a pet can’t be optimally healthy unless they’re also happy.
"Fear, anxiety, and stress (FAS) raise the levels of hormones that are destructive to both the body and mind.
"Fear Free uses clinically proven protocols to remove or reduce FAS triggers, it takes steps to mitigate FAS so that the pet feels safe and calm during a veterinary visit.”
Since launch, over 320,000 veterinary professionals, pet professionals, animal welfare communities, and pet owners have registered for Fear Free’s programmes and courses, and Fear Free says it has become the accepted gold standard within North American veterinary practices.
Yvette Rowntree, Clinic Director at Harrison Family Vets in Reading, said: “This accreditation process has taken everything we do to the next level.
"With open and honest team conversations, development of realistic protocols and a subtle change in behaviours to ensure we always put the pet first within a supportive work environment, our entire team has worked hard to achieve this certification.”
Operations Director, Kristie Faulkner, from Harrison Family Vets, said: “Although it was possible for individuals to be Fear Free certified, this is the first time an entire practice has become certified.
"We have worked very closely with the Fear Free team during the past several months to enable detailed inspection and certification to take place, and we now intend for our other practices, in Dudley, Didsbury, Stockton, and Doncaster, to each reach this standard and become officially certified in the immediate future.”
Fear Free’s CEO, Randy Valpy, said: “Harrison Family Vets’ certification is part of the Fear Free expansion into the UK, New Zealand and Australia and we are absolutely thrilled to have the Reading practice as our first UK Fear Free Certified Veterinary Practice.
"We now plan to certify further practices in the UK and support veterinary professionals who have the relevant knowledge and techniques to practise quality medicine, as well as understanding how to develop the utmost consideration for patient’s emotional health as well.”
https://fearfreepets.com
The findings of a Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, have demonstrated the efficacy of Advantix in repelling ticks and sandflies, thus reducing the risk of potentially deadly diseases.
The study, conducted over two years by a team headed by Professor Domenico Otranto of the Faculty of Veterinary Medicine (Universitá degli Studi di Bari) Italy, with diagnostic support from a team led by Dr. Edward Breitschwerdt at the North Carolina State University, USA, found that dogs treated regularly with Advantix spot-on had a greater than 90% reduction in CVBD cases, including a 100% reduction in new cases of potentially deadly leishmaniosis and a 94.6% decrease in ehrlichiosis.
The study also found that Advantix provided 97.9% protection against tick infestation, compared to untreated dogs, where 100% were infested at the peak of the season. The level of protection offered by Advantix was apparently all the more notable because of particularly large numbers of ticks and sand flies and high prevalence of associated diseases like leishmaniosis or babesiosis in the area of the study.
Prof. Otranto said: "Our study shows the importance of protecting dogs with an effective treatment that repels as well as kills parasites like ticks and sand flies. Despite the high challenge faced by the dogs in our study, nearly all our treated dogs remained free from ticks throughout most of the study, and more than 90% remained free from CVBDs for the whole study time.
"Because we included naïve sentinel beagles in the study, we were also able to model what would happen to dogs travelling to areas where CVBDs are present. We found that by the end of the study, only the Advantix-treated beagles remained protected from infection, while 80% of the untreated beagles were infected with a CVBD. This demonstrates the very real need to protect dogs that are travelling to endemic areas."
According to Bayer, the study showed some interesting results with dogs that were positive with CVBDs when they entered the study. Of these, half of those treated with Advantix were negative for CVBDs at the end of treatment, compared with only 13% of untreated dogs. This suggests the potential for natural clearance of CVBDs if a repellent treatment is used to prevent new transmissions.
Bayer says the study was extremely comprehensive, studying both indigenous and introduced naïve puppies, monitoring for several CVBDs and working with Dr. Breitschwerdt's team in the USA to use highly sensitive molecular testing techniques to ensure optimal diagnostic accuracy. Dr. Breitschwerdt said: "This is the most comprehensive study, to my knowledge, ever conducted testing the efficacy of a repellent ectoparasiticide to prevent the transmission of a spectrum of CVBDs in young dogs."
Leading parasitologist Dr. Luis Cardoso of the University of Trás-os-Montes e Alto Douro, Portugal said: "Thanks to this study we can see just how effective a treatment that repels as well as kills can be."
Veterinary surgeons are being called on to help recruit dogs for a clinical study called EPIC - the Evaluation of Pimobendan In dogs with Cardiomegaly caused by pre-clinical mitral valve disease (MVD).
The long-term study, which is supported by Boehringer Ingelheim, will assess whether using pimobendan in the pre-clinical phase of MVD has a benefit in extending the time to the onset of clinical signs. It involves 36 centres globally with the aim of recruiting 360 dogs in total. In order for dogs to be eligible for the study they must:
The three veterinary cardiologists from the UK involved in the randomised, double-blinded, placebo-controlled, parallel group study are Adrian Boswood MA VetMB DipECVIM-ca DVC MRCVS from the Royal Veterinary College (the RVC) in Hertfordshire, Sarah Smith MA VetMB DVC MRCVS from Sarah Smith Cardiology in Derbyshire and Mark Patteson MA VetMB, PhD DVC CertVR MRCVS from Heart Vets at Vale Referrals, Gloucestershire.
Adrian Boswood, veterinary cardiologist from RVC said: "The implications of this study for dogs and their owners could be enormous. If the research shows that pimobendan is effective before clinical signs of MMVD appear, this could lead to a new treatment option for practitioners."
For further information on the study or if you have a dog that may be suitable for the trial, please contact the nearest study investigator - Adrian Boswood on 01707 666605, Sarah Smith on 07515 359241 or Mark Patteson on 01453 547934.
This year's National Equine Health Survey, conducted by the Blue Cross and supported by Zoetis, has revealed that 20% of owners who claimed to have treated for encysted small redworm (ESRW) used a wormer that was not indicated to treat the parasite.
3,669 horse owners took part in the survey, which was conducted in May 2014. It contained 25 questions on general horse health, care and management and was validated by Professor Josh Slater at the Royal Veterinary College.
Zoetis says the findings suggest that horses are being left at serious risk (untreated, encysted small redworm may develop and emerge en masse from the gut wall, causing diarrhoea and colic with a mortality rate of up to 50%1).
The company is now running an encysted small redworm awareness campaign at www.esrw.co.uk, where owners can test their knowledge before discussing the best treatment options with their vet.
References
1. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242
The Bella Moss Foundation (BMF) has launched a free practice hygiene audit tool.
The BMF Practice Hygiene Self Audit is a web-based assessment tool that allows staff to monitor cleanliness across the practice – from theatre and prep rooms to laundry and waiting rooms.
The tick sheet format allows staff to rate the hygiene protocols in each area, resulting in a room-by-room percentage hygiene score, as well as an overall contamination risk score.
The tool was developed by vet and RCVS Practice Standards Scheme (PSS) expert Pam Mosedale and VN lecturer Louise O'Dwyer, along with Edinburgh academic Tim Nuttall and Chris Laurence.
Pam said: "Given the relaunch of the PSS later in the year, which will include new modules on infection control, the BMF audit tool is especially timely.
"We hope that people will try the audit tool and it will lead them to have more of a team discussion about hygiene routines and protocols in practice. We know some areas get more attention than others - for example, how often do things like the toys in the waiting area really get cleaned?
“By using the audit, staff will easily be able to see what rooms/areas might need a bit more cleaning.
She added: "It's a simple no-frills tool but the whole idea is for it to be helpful and easy to use, so more practices are encouraged to have regular quantifiable monitoring systems in place to keep an eye on their hygiene protocols."
Co-creator Louise O'Dwyer said: “The BMF Practice Hygiene Self Audit will help ensure often overlooked aspects of cleaning and infection control are considered and implemented.
“It needs to be embraced by all members of staff, from non-clinical staff through to veterinary surgeons, as every individual has the potential to make an impact within their practice by taking action on infection control.”
To test the tool and see how clean your practice is, go to: www.thebellamossfoundation.com/practice-hygiene-self-audit
Every two years, the Plowright Prize will offer £75,000 to recognise an individual working in Europe or the Commonwealth who has made a significant impact on the control, management and eradication of infectious diseases of animals.
Eligible activity must demonstrate animal, humanitarian or economic benefit. The prize money is intended to support the individual’s ongoing work in the field.
Potential recipients of the prize include veterinary surgeons, veterinary nurses and research scientists. Awardees may be working in a research setting, in academia, in practice or in other related sectors. Individuals must be nominated for the award, and the prize is not open to organisations.
Nominations are now invited for the inaugural prize, and must be received by 31st March 2020.
Executive Director of RCVS Knowledge Chris Gush said: "We are honoured to be launching the Plowright Prize in memory of one of the world’s most exceptional veterinary surgeons and scientists, and in celebration of decades of dedication to an area of substantial societal significance.
"It is our belief that this prestigious international prize will help stimulate further research and improvement activities, including supporting the development of expertise in the area of infectious disease within the veterinary profession."
Walter Plowright (1923-2010) was an acclaimed veterinary scientist whose major breakthrough in the battle against rinderpest – the tissue culture rinderpest vaccine (TCRV) – provided the key to eliminating the disease. In the year of Walter’s death, the Food and Agriculture Organization of the United Nations officially announced the complete eradication of the disease, only the second such feat in human history, alongside smallpox.
The story behind the profession’s eradication of rinderpest, commonly known as cattle plague, can be read in RCVS Knowledge’s publication Evidence-Based Veterinary Medicine Matters.
In 2023, the prize will celebrate 100 years since Walter Plowright’s birth with a special award of £100,000 to that year’s winner.
Full criteria for the Plowright Prize can be found on the RCVS Knowledge website: https://knowledge.rcvs.org.uk/grants/available-grants/plowright-prize-2019/.
Photo: Helen Leeds
The Association of Private Pet Cemeteries & Crematoria (APPCC) has launched a new leaflet for bereaved pet owners, which will be distributed to veterinary practices.
Kevin Spurgeon, Director of the APPCC said: "The feelings of grief and loss that pet owners go through after the death of their pet is often not fully appreciated. The idea of the leaflet is to help owners understand and deal with the emotions they are experiencing more. If the pet is part of a family then several people along with other pets may be affected - it may even be the first experience of death for some."
The leaflet was written and produced for the APPCC by Jane Matthews, author of Losing a Pet (http://www.smallbooks.co.uk/), and has had support from several experienced pet bereavement counsellors and the nationwide Pet Bereavement Support Service run by SCAS (www.scas.org.uk). It covers a variety of subjects, including:
According to the APPCC, studies have shown that as many as 1 in 4 pet owners take time off of work after the death of their pet with nearly half of all those surveyed having taking annual leave after their loss. Pet crematoriums have also noticed an upturn in the numbers of people taking a hands-on approach by choosing to arrange an individual cremation for their pet directly with the crematorium.
The APPCC plans to distribute the leaflets to its members, pet bereavement counsellors and veterinary surgeries throughout the UK and believes this is a major step forward in both acknowledging pet bereavement and helping those affected by it. The leaflet will also be available to download from the main APPCC website www.appcc.org.uk as well as through many of the members own sites.
This brings the total reported the UK so far this year to eight, following 28 last year and 287 in total.
For a map of all confirmed cases and information for veterinary professionals and pet owners about CRGV, visit: www.alabama-rot.co.uk.
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction or elimination of feline urine marking.
Ceva says this is the first time a meta-analysis technique has been used to evaluate the efficacy of interventions in veterinary behavioural medicine; the study assessed all published papers covering treatments for feline urine spraying. Ten studies in nine publications were analysed, despite their different study designs. In order to carry out the meta-analysis, the papers were rated according to importance and a 'placebo-effect' was calculated. Primary and secondary outcomes were also identified, with the primary outcome being the 'number of cats that either ceased or reduced spraying by at least 90%' and the secondary outcome being 'the number of cats that reduce spraying from baseline levels'.
Information is available by calling Lucy Brett at CEVA Animal Health on 01494 781510.
1. A meta-analysis of studies of treatments for feline urine spraying. Daniel S Mills, Sarah E Redgate, Gary M Landsberg. PLos ONE, April 2011, Volume 6, Issue 4
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
Zoetis Business Consulting has released figures showing that Profit Solver, its financial analysis tool, has delivered an average EBITDA (earnings before interest, taxes, depreciation and amortization) growth of 36% for the 28 UK practices that have used the new service since its launch.
Profit Solver was first launched in the USA, where the company says more than 300 practices have now benefited from the service.
Zoetis says that traditionally, veterinary practices have set their prices by simply adding a set mark-up, without knowing which services make a profit or loss and without understanding exactly how overall practice profit is being generated.
Profit Solver instead uses the practice’s own data to calculate the exact cost for the 130 most commonly performed veterinary services, representing 90% of the revenue generated by the practice. It then combines labour, inventory and equipment costs with time-and-motion studies for each service, and assesses the variance between cost and price to reveal profit or loss.
By using a collection of cost data, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profit Solver calculates the correct pricing to both cover costs and deliver a pre-determined profit margin.
Implementing Profit Solver is done with a Zoetis business consultant who guides the practice through the process, from data collection to examining the time-and-motion studies. They discuss the level of profitability the practice needs to deliver and help analyse prices to achieve this goal whilst preserving the price-point of highly competitive services and covering all the practice’s costs.
Ian Camm, Group Director of B&W Equine Vets in Gloucestershire heard about Profit Solver from a vet in a neighbouring practice who was impressed with how it had helped his business. Ian discussed Profit Solver with his Zoetis account manager and booked an appointment with Zoetis Business Consultant Anthea Pike who has helped him implement the software across B&W Equine Group.
He said: "Initially I was concerned that Profit Solver would suggest we put prices up where we felt that we would not be able to - people shop around for their veterinary services these days and many services are very price sensitive. The first stage in the process addressed this by looking at our figures, calculating the cost price for each procedure and then, by comparing with our fees charged, identified where we were losing money. The big question was whether we would be comfortable to increase our fees on loss-making procedures. The beauty of the system was that by looking at a large number of procedures which were done frequently, very small increases in fee would total to a significant improvement in the bottom line.
"The software has made us recognise where the real costs are and how to address these areas accordingly, for example we have identified that current stud packages are not profitable. One of the problems in arriving at true costs is the difficulty in accurately allocating time to various procedures when several different vets are involved or an expensive scanner is used, which can have a significant impact on the results. It’s early days, but I can already see the difference that Profit Solver could make to our bottom line and wouldn’t hesitate to recommend it providing the practice is prepared to make changes in light of the results. We are looking at improving our bottom line by a six figure sum over a 12 month period with what we hope, will be hardly noticeable price rises.”
For further information visit www.zoetis.co.uk/businessconsulting.
Ian also discusses the most effective treatment and prevention strategies: "“With surveys showing deworming frequencies below those recommended by ESCCAP and concerns surrounding over treatment of cats and dogs, there has never been a more important time to examine the importance of routine roundworm prevention. Without adequate control of Toxocara canis and Angiostronglyus vasorum, the impact on owners and their pets can be considerable."
The webinar can be viewed here: https://www.elearning.vet/watch/65
Produced in association with Farmers Guardian, information in the guide includes the role of Multimin in increasing farm margins by reducing mastitis, improving fertility, assisting growth and increasing immunity.
The Multimin Focus Guide also includes case studies that demonstrate how livestock performance can be elevated with trace minerals, which is relevant to both the dairy and beef industries.
Sabrina Jordan, Product Manager at Virbac said: "Multimin is a unique injection that is designed to ‘top up’ trace mineral supplies at critical times of the production cycle.
"Strategic use of Multimin supports the transition cow and is increasingly used to increase fertility in maiden heifers, particularly at second lactation.
"Multimin is particularly useful for youngstock where it helps to boost immunity and growth; and supports during times of stress such as transportation and grouping.
"Most significantly, in areas where vets have identified deficiencies in grazing pasture, Multimin can ensure that animals are 'topped up' with the appropriate trace minerals to optimise performance.
"The aim of this online resource is to support vets in demonstrating the importance of trace minerals to improving herd efficiency and health."
www.farmersguardian.com/bringing-herd-health-virbac-multimin-focus
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.
Key Note Ltd, has published Pet Insurance 2015, a report into the state of the UK pet insurance market which forecasts that premiums will rise by 46.7% by 2019.
The report notes that the percentage of adults in Great Britain owning at least one dog has increased by 2.1 percentage points over the past 5 years, and the percentage owning at least one cat is 2.5 percentage points higher than it was 5 years ago. Yet despite growth in the pet population, the increase in the volume of pet insurance policies (23.6% between 2010 and 2014) has been far exceeded by the increase in the value of premiums written (40.7%).
Key Note says claims inflation has been a major factor in rising premiums; despite gross written premiums for cats, dogs and other pets increasing by 13.3% between 2013 and 2014 alone, the cost of claims for the same animals rose by 14.7% over the same period, over and above the premium increases seen.
According to the company, rising claims are largely down to the increasing cost of veterinary treatment — as advances in pet medicine increase apace with those in human medicine, treating pets is getting more costly. Not only this, but other factors, such as the rise in overweight or obese pets and even antibiotic-resistant bacteria, both common problems in the human health service, are also pushing up the costs of veterinary treatment.
In other general insurance markets, most notably motor insurance, which price comparison websites (PCWs) were initially set up to focus on, competition exerts a major downward pressure on premiums. However, the report says this is not always the case in the pet insurance market. This is because it can be difficult for those who have already claimed on pet insurance policies to switch insurers; the result of doing so is often that the condition the pet has previously been treated for is classed as ‘pre-existing’ in the new policy and therefore it, and related conditions, will not be covered under the new policy. This could leave pet owners liable to pay for veterinary treatment in full.
The situation has been further exacerbated by the high-profile withdrawal of a number of underwriters from the pet insurance market. The nature of the pet insurance market, though at first seeming diverse, actually involves a relatively limited pool of underwriters behind the numerous brands available. The report details how just four underwriters between them either underwrite or, at the very least, arrange and administer the pet insurance policies of 27 of the foremost brands in the pet insurance market.
Key Note forecasts that although insurance companies will see an increase in the volume of pets insured, this will not compensate for the relentless increase in the cost of claims which will be largely responsible for driving the cost of pet insurance up 46.7% by 2019.
All existing BEVA members will have their membership automatically extended until 30 June 2020. The association is also inviting vets and vet nurses who are not already BEVA members to join as online members free of charge until 30 June 2020.
BEVA President Tim Mair said: “In this extraordinary time of global crisis our profession, as with many industries, is under immense pressure. By offering free membership we are giving equine vets easy access to a wealth of supportive resources and online CPD to help them through these dark times.”
BEVA membership includes:
The association is also looking at other ways to support the profession, which has included making all BEVA Congress 2019 webinars available to members via the BEVA online learning platform.
To sign up from Monday 30 March 2020 visit: https://www.beva.org.uk/Join-BEVA
One set of guidelines deals with intoxication from pyrethrins commonly found in flea control products or ant powders, whilst the other covers macrocyclic lactone poisoning which most often occurs due to accidental ingestion of large animal anthelmintic products.
Both intoxications are commonly associated with severe neurological symptoms.
Will Peel, Product Manager at TVM UK said: "Our guidelines have proved very useful to veterinary staff and we have received requests from vets to add new guidelines for antiparasiticide intoxications. Our focus is on helping veterinary staff provide the best possible care for their patients so we hope that these new guidelines will prove beneficial."
The guidelines can be downloaded free from https://www.tvm-uk.com/vet-resource-library.